These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 17722472

  • 1. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
    Madry K, Dwilewicz-Trojaczek J, Suleiman W, Paszkowska-Kowalewska M, Ziarkiewicz-Wróblewska B.
    Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F, Krauth MT, Vales A, Böhm A, Agis H, Sonneck K, Aichberger KJ, Mayerhofer M, Simonitsch-Klupp I, Müllauer L, Sperr WR, Valent P.
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR, Liu T, Meng WT, Yu J, Niu T.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [Abstract] [Full Text] [Related]

  • 5. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.
    Alexandrakis MG, Passam FH, Pappa CA, Damilakis J, Tsirakis G, Kandidaki E, Passam AM, Stathopoulos EN, Kyriakou DS.
    Int J Immunopathol Pharmacol; 2005 Jan; 18(2):287-95. PubMed ID: 15888251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
    Patsouris E, Korkolopoulou P, Androulaki A, Douzinas E, Kosmopoulou O, Kordossis T.
    Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
    Kim CK, Han DH, Ji YS, Lee MS, Min CW, Park SK, Kim SH, Yun J, Kim HJ, Kim KH, Lee KT, Won JH, Hong DS, Kim HK.
    Leuk Res; 2016 Nov; 50():21-28. PubMed ID: 27639703
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Angiogenesis and survival in patients with myelodysplastic syndrome.
    Savic A, Cemerikic-Martinovic V, Dovat S, Rajic N, Urosevic I, Sekulic B, Kvrgic V, Popovic S.
    Pathol Oncol Res; 2012 Jul; 18(3):681-90. PubMed ID: 22270865
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z, Xie J.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes.
    Cortelezzi A, Fracchiolla NS, Mazzeo LM, Silvestris I, Pomati M, Somalvico F, Bertolini F, Mancuso P, Pruneri GC, Gianelli U, Pasquini MC, Cortiana M, Deliliers GL.
    Leuk Lymphoma; 2005 Sep; 46(9):1345-51. PubMed ID: 16109613
    [Abstract] [Full Text] [Related]

  • 18. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS, Meugé-Moraw C, Schmidt PM, Parlier V, Jotterand M, Delacrétaz F.
    Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
    [Abstract] [Full Text] [Related]

  • 19. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
    Alexandrakis MG, Passam FH, Pappa CA, Sfiridaki K, Tsirakis G, Damilakis J, Stathopoulos EN, Kyriakou DS.
    Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
    [Abstract] [Full Text] [Related]

  • 20. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
    Marković O, Marisavljević D, Cemerikić V, Vidović A, Perunicić M, Todorović M, Elezović I, Colović M.
    Med Oncol; 2008 Jan; 25(4):451-7. PubMed ID: 18449811
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.